Shi, Y., Zhang, J., Xin, X., Liu, L., Wu, Y., Cheng, Y., . . . Zhao, Y. (2025). Effects of dapagliflozin on podocyte damage and oxidative stress in patients with diabetic nephropathy. Diabetology & Metabolic Syndrome, 17(1), 1. https://doi.org/10.1186/s13098-025-01886-3
Chicago Style (17th ed.) CitationShi, Yajing, Jingjing Zhang, Xiaoxiao Xin, Lixia Liu, Yaru Wu, Yanli Cheng, Li Zhang, Hong Su, and Yuebin Zhao. "Effects of Dapagliflozin on Podocyte Damage and Oxidative Stress in Patients with Diabetic Nephropathy." Diabetology & Metabolic Syndrome 17, no. 1 (2025): 1. https://doi.org/10.1186/s13098-025-01886-3.
MLA (9th ed.) CitationShi, Yajing, et al. "Effects of Dapagliflozin on Podocyte Damage and Oxidative Stress in Patients with Diabetic Nephropathy." Diabetology & Metabolic Syndrome, vol. 17, no. 1, 2025, p. 1, https://doi.org/10.1186/s13098-025-01886-3.